GlaxoSmithKline reaches agreement with Aspen to divest thrombosis brands and related manufacturing site for £0.7 billion
Divestment supports strategic focus and delivery of pipeline.
Source: GSK news - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Thrombosis